
Omicron Proving to Be Nothing to Sneeze At
Only a small percentage of the Omicron variant of COVID-19 cases require hospitalization so far, but high infectivity may turn this small percentage into a large number of patients, which will further stress our health care system.
Two new reports shed light on Omicron. The first is from the
All but one participant reported symptoms. Most reported onset within 3 days. “Over 70% of cases reported cough, lethargy, headache, sore throat and over half of them reported fever. No hospital admissions have been reported.”
The vast majority of participants were vaccinated with a two-dose mRNA vaccine.
The second is from the Centers for Disease Control and Prevention (CDC), which described the initial 43 Omicron cases in the United States. Almost 80% (34) were fully vaccinated and 14 individuals had
The bottom line is that initial data from small studies indicates that vaccines and boosters protect against hospitalizations and death, but not infections. Overall, there is only a small percentage of cases which appear to require hospitalization.
However, the high infectivity of Omicron may turn this small percentage into a large number of patients, which risks further stressing our health care system. We need to remember that Omicron is not Delta becoming less virulent. It had a separate evolutionary pathway possibly
In the United Kingdom, it has been observed that the Omicron variant causes less severe disease, but it risks overwhelming their health care system with 5 thousand admissions to the
Everyone needs to become vaccinated. Hopefully, each variant will add to a broadening of our immunological response and result in a progressive lessening of disease severity.
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.






